Search company, investor...

Apneon

apneon.com

Founded Year

2003

Stage

Series B | Alive

Total Raised

$17.1M

Last Raised

$12M | 17 yrs ago

About Apneon

Apneon is an early stage medical device company developing devices for the treatment of sleep apnea.

Headquarters Location

20813 Stevens Creek Boulevard Suite 100

Cupertino, California, 95014,

United States

408-579-9200

Missing: Apneon's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Apneon's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Apneon

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Apneon is included in 1 Expert Collection, including Sleep Health & Wellness.

S

Sleep Health & Wellness

802 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

Apneon Frequently Asked Questions (FAQ)

  • When was Apneon founded?

    Apneon was founded in 2003.

  • Where is Apneon's headquarters?

    Apneon's headquarters is located at 20813 Stevens Creek Boulevard, Cupertino.

  • What is Apneon's latest funding round?

    Apneon's latest funding round is Series B.

  • How much did Apneon raise?

    Apneon raised a total of $17.1M.

  • Who are the investors of Apneon?

    Investors of Apneon include Split Rock Partners, Frazier Healthcare Partners, Cutlass Capital and Pequot Venture Capital.

  • Who are Apneon's competitors?

    Competitors of Apneon include ALung Technologies, MedShape, iTind, Mobius Therapeutics, Autonomic Technologies, Cianna Medical, Inspire Medical Systems, TearScience, LinguaFlex, TRIA Beauty and 12 more.

Compare Apneon to Competitors

L
LinguaFlex

Linguaflex is a medical device company with a patent pending technology to treat obstructive sleep apnea. LinguaFlex's LTR is implanted and designed to be comfortable, therefore addressing the lack of compliance as an issue in the successful treatment of OSA.

P
Portaero

Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).

N
Neuromonics

Neuromonics is an Australian company that has developed an FDA approved device for treatment of tinnitus over a six month process with 2 hours of use per day.

M
Monterey Devices

Stealth mode medical device company developing devices for drug delivery. Monterey Devices submitted a patent on device for buffering anesthetics.

V
Vascure

Vascure is a medical device company. The company is developing an therapeutic device for percutaneous treatment of arterial disease. Vascure's system will offer a one-stop solution for restoring blood flow to narrowed or occluded blood vessels in a range of clinical conditions, including heavily calcified lesions. Vascure will provide Intervantionalists with a safe and easy to use device, shortening procedure time, allowing percutaneous treatment in cases previously requiring radical surgical procedures and generating improved clinical outcomes.

V
Valor Medical

Valor Medical is a San Diego-based medical device company that has developed liquid embrolic technology for the treatment of cerebral aneurysms.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.